期刊文献+

导向溶栓分子scFv-UK32中连接肽的引入和在昆虫细胞中的表达 被引量:1

Introduction of A Linking Peptide to the Thrombolysis-TargetedProtein and Its Expression in Insect Cell
下载PDF
导出
摘要 为了提高重组导向溶栓分子scFv UK32的溶纤活性 ,通过重组PCR方法在编码scFv与UK32的碱基之间引入编码KLGGGG连接肽的碱基序列 ,并克隆到转移载体pBacPAK9上 ,通过与线性病毒DNABacPAK6 Bsu36Idigest共转染到昆虫细胞Sf 9内 ,进行表达。表达产物分泌到上清中 ,共转染后第 5d(天 )用纤维平板法测得Sf 9细胞上清溶纤活性达到 10 7IU mL ,比未引入连接肽的scFv UK32的表达活性 (2 5IU mL)高。ELISA实验表明共转染上清具有明显对活化血小板特异结合能力。WesternBlotting实验表明共转染上清可与Pro UK的单抗特异结合。 The recombinant PCR technic was used to introduce a linking peptide (KLGGGG) to the site between scFv(single chain form of the monoclonal antibody SZ-51 specific for the glycoprotein GMP140 on activated platelet membrane) and UK32 (low molecular weight form of pro-urokinase),to make the scFv-linker-UK32 chimeric gene.This gene was cloned into the transfer vector pBacPAK9,and cotransfected with BacPAK6/Bsu36I digest into Sf 9 cells.The fusion protein was secreted into the medium.In the fifth day after the cotransfection,the supernatant of the medium showed 107 IU/mL fibrinolytic activity,higher than 25 IU/mL fibrinolytic activity of scFv-UK32.ELISA showed that the supernatant had the binding activity to activated platelet.Wastern Blotting also indicated that the supernatant could bind to the monoclonal antibody of urokinase B chain.
出处 《北京大学学报(自然科学版)》 CAS CSCD 北大核心 2001年第6期785-790,共6页 Acta Scientiarum Naturalium Universitatis Pekinensis
基金 863高科技资助项目 ( 863 10 2 0 9)
关键词 导向溶栓分子 连接肽 昆虫细胞 表达 scFv-UK32 重组PCR方法 溶栓药物 targeted thrombolysis linking peptide insect cell expression
  • 相关文献

参考文献3

二级参考文献2

共引文献3

同被引文献12

  • 1韩小艳,赵娜,王永祥.接头序列及其在融合蛋白构建中的应用[J].河北医科大学学报,2007,28(3):224-227. 被引量:12
  • 2EL-Andaloussi,Holm S,Langel ü T. Cell-penetrating peptides:mechanisms and applications[J].Current Pharmaceutical De-sign,2005,(11):3597-3611.
  • 3Henrik J Johansson,Samir El-Andaloussi. Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein[J].{H}Molecular Therapy,2008,(1):115-123.
  • 4Niarchos D K,Perez S A. Characterization of a novel cell penetrating peptide derived from Bag-1 protein[J].{H}PEPTIDES,2006,(11):2661-2669.
  • 5Zhao J,Gao P. A novel human derived cell-penetrating peptide in drug delivery[J].Molecular Biology Report,2011,(4):2649-2656.
  • 6Frankel A D,Pabo C O. Cellular uptake of the tat protein from human immunodeficiency virus[J].{H}CELL,1988.1189-1193.
  • 7Green M,Loewenstein P M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein[J].{H}CELL,1988.1179-1188.
  • 8Gustavsson M,Lehtio J,Denman S. Stable linker peptides for a cellulose-binding domain-lipase fusion protein expressed in pichia pastoris[J].{H}Protein Engineering,2001,(9):711-715.
  • 9Crasto C J,Feng J A. LINKER:a program to generate linker sequences for fusion proteins[J].{H}Protein Engineering,2000,(5):309-312.
  • 10Ryoichi A,Hiroshi U,Atsushi K. Design of linkers which effectively separate domains of a bifunctional fusion protein[J].{H}Protein Engineering,2001.529-532.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部